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Rho GTPaseLysophosphatidic acid (LPA) acts as a potent stimulator of tumorigenesis. Cell–cell adhesion disassembly,
actin cytoskeletal alterations, and increased migratory potential are initial steps of colorectal cancer progres-
sion. However, the role that LPA plays in these events in this cancer type is still unknown. We explored this
question by using Caco-2 cells, as colon cancer model, and treatment with LPA or pretreatment with different
cell signalling inhibitors. Changes in the location of adherent junction proteins were examined by immuno-
ﬂuorescence and immunoblotting. The actin cytoskeleton organisation and focal adhesion were analysed by
confocal microscopy. Rho-GTPase activation was analysed by the pull-down assay, FAK and Src activation by
immunoblotting, and cell migration by the wound healing technique. We show that LPA induced adherent
junction disassembly, perijunctional actin cytoskeletal reorganisation, and increased cell migration. These
events were dependent on Src, Rho and Rock because their chemical inhibitors PP2, toxin A and Y27632, re-
spectively, abrogated the effects of LPA. Moreover, we showed that Src acts upstream of RhoA in this signal-
ling cascade and that LPA induces focal adhesion formation and FAK redistribution and activation in conﬂuent
monolayers. Focal adhesion formation was also observed in the front of migrating cells in response to LPA,
and Rock inhibitor abolished this effect. In conclusion, our ﬁndings show that LPA modulates adherent junc-
tion disassembly, actin cytoskeletal disorganisation, and focal adhesion formation, conferring a migratory
phenotype in colon tumour cells. We suggest a functional regulatory cascade that integrates RhoA–Rock
and Src–FAK signalling to control these events during colorectal cancer progression.: +55 21 3207 6587.
-Díaz).
vier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Lysophosphatidic acid (LPA) is a natural phospholipid related to a
broad range of cellular responses, such as cell proliferation, migration
and survival. This bioactive lipid is present at high levels in the plas-
ma and ascitic ﬂuid of ovarian cancer patients (Erickson et al.,
2001). Although high levels of lysophosphatidylcholine, a LPA precur-
sor, were found in the plasma of colorectal patients (Zhao et al.,
2007), few studies have focused on the role that LPA plays during
the progression of this neoplasia.
LPA evokes its cellular responses through its G protein-coupled re-
ceptors, LPA1-6, which can stimulate multiple downstream signalling
pathways. For example, LPA can activate Erk (Zhang et al., 2007), Src
(Huang et al., 2008), PKA (Müller et al., 2010), Rho and Rac GTPases
(Harper et al., 2010; Yamada et al., 2005), and transactivate EGFR
(Mori et al., 2006). In colon cancer, the fact that LPA1-3 receptors are ab-
errantly expressed (Müller et al., 2010) implicates a role during tumourprogression. For instance, in a model of colitis using Apc (min/+)
mice, the absence of LPA2 attenuates tumour formation (Lin et al.,
2009).
Epithelial adherent junctions encircle E-cadherin, which interacts
with the neighbouring cell through its ectodomain and with the
actin cytoskeleton through its cytoplasmic domain via p120-catenin,
β-catenin and α-catenin (Huang et al., 2008; Leve et al., 2008). Various
studies have shown that the downregulation of adherent junctions is
related to cell migration, invasion and metastasis of epithelial tumour
cells (Syed et al., 2008). Nevertheless, there are few studies showing
that LPA can modulate adherent junction disassembly in colon cancer.
It has been shown that long-term LPA treatment caused nuclear trans-
location of β-catenin, inducing the proliferation of colon cancer cells
(Yang et al., 2005). Additionally, LPA-induced adherent junction disso-
ciation leads to β-catenin and E-cadherin localisation at the perinuclear
endocytic recycling compartment in invasive colon cancer cells (Kam
and Quaranta, 2009). However, whether LPA induces adherent junction
disruption tomodulate actin cytoskeletal disorganisation in colon cancer
cells and the cell signalling pathways underlying this process remain to
be deﬁned.
It is known that cell–cell adhesion, actin cytoskeletal dynamics
(Leve et al., 2008), and cell migration (Pertz et al., 2006) are
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events related to cell migration, such as stress ﬁbre and focal adhe-
sion formation at the cell–matrix adhesion, through the activation
of Rho–Rock signalling in different cell lines (Ridley and Hall, 1992;
Zhang et al., 2007). However, the molecular mechanism of LPA-in-
duced cell migration in colon cancer remains poorly understood. In
the present study, we demonstrate that the treatment of Caco-2 cells
with LPA causes adherent junction disassembly and actin cytoskeletal
disorganisation, leading to increased cell migration. Furthermore, we
report that LPAmodulates these events through a functional regulatory
cascade that integrates RhoA–Rock and Src–FAK signalling to control
colon cancer progression.
2. Materials and methods
2.1. Antibodies and reagents
Mouse monoclonal anti-E-cadherin (clone 36) was purchased from
BD Biosciences (San Diego, CA, USA). L-α-lysophosphatidic acid (oleoyl
sodium), mouse anti-p120-catenin (6H11), mouse anti-IQGAP1 and
mouse anti-α-tubulin (Z022)were purchased from Invitrogen Corpora-
tion (Carlsbad, CA, USA). Rabbit anti-Rock II, monoclonal anti-Rac
(23A8), rabbit anti-phospho-FAK (Tyr 397), rabbit anti-p125 FAK, and
rabbit anti-β-catenin were obtained from Sigma-Aldrich (Saint Louis,
MO, USA). Mouse anti-phospho-Src (Tyr 416, 100F9 rabbit) was
obtained from Cell Signaling Technology, Inc. EZ-Detect TM Rho and
Rac activation kits for pull-down assays, including anti-Rho and anti-
Rac antibodies, were obtained from Pierce (Rockford, IL, USA). The
Alexa 488-conjugated secondary antibody was obtained from Invitro-
gen Corporation. Horseradish peroxidase-conjugated goat anti-rabbit
and anti-mouse IgG were obtained from Sigma-Aldrich. H-89 (N-
[2-(p-bromocinnamylamino) ethyl]–5–isoquinolinesulfonamide)
and LY294002 (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-
one) inhibitors were purchased from Biomol Research Laboratories
Inc. (Plymouth Meeting, PA, USA). PD153035 (4-[(3-bromophenyl)
amino]-6,7-dimethoxyquinazoline, Y-27632 ((R)-(+)-trans-N-(4-
Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide), toxin A from
Clostridium difﬁcile and PP2 (4-amino-5-(4-chlorophenyl)-7-
(t-butyl) pyrazolo[3,4-d]pyrimidine were purchased from Calbio-
chem (Darmstadt, Germany).
2.2. Cell culture and LPA treatment
The Caco-2 human colon adenocarcinoma cell line (ATCC, #HTB-37)
was passaged weekly with 0.05% trypsin/0.02% EDTA in PBS solution.
The cells were grown in Dulbecco's modiﬁed Eagle medium (DMEM)
supplemented with 10% foetal bovine serum (FBS), penicillin G
(60 mg/l) and streptomycin (100 mg/l) at 37 °C in a humidiﬁed atmo-
sphere of 5% CO2/air.
Cell cultures were switched to serum-free medium for 24 h prior to
LPA treatment. We tested concentrations of 1, 10 or 20 μM of LPA and
used confocal microscopy to ﬁnd that 10 μM was the minimal concen-
tration that induced stress ﬁbre formation in our model. Thus, using
this concentration, which was also used in previous studies (Shida et
al., 2008; Yamada et al., 2005), we analysed the effect of LPA on
Caco-2 cells at the indicated times.
2.3. Treatments with pharmacological inhibitors
Selective pharmacological inhibitors were added to the cell cul-
tures 1 h before LPA treatment and were present throughout the
treatment as indicated. The inhibitorswere diluted in DMSO and stored
at−20 °C. Each concentrated solution was diluted immediately before
use to give ﬁnal concentrations as follows: 100 nM PP2 (Src inhibitor),
20 μM H-89 (PKA), 100 nM PD153035 (EGFR), 10 μm LY294002(PI3K), 10 μM toxin A from Clostridium difﬁcile (Rho), and 10 μM
Y-27632 (Rock).2.4. Immunoﬂuorescence and actin cytoskeleton detection
Caco-2 cell monolayers were grown on sterile glass coverslips and,
after the treatments, washed in PBS, ﬁxed in 4% paraformaldehyde,
and incubated in NH4Cl for 10 min at room temperature. The cells
were then permeabilised with 0.5% Triton X-100 and blocked with
3% BSA in PBS for 2 h. Subsequently, the cells were incubated overnight
at 4 °C in primary antibodies against E-cadherin (1:100), β-catenin
(1:220), p120-catenin (1:200), RhoA (1:200), Rock II (1:500), Rac1
(1:60), IQGAP (1:50) and FAK (1:1000), followed by 1 h in the respec-
tive Alexa 488-conjugated secondary antibodies (1:500). The cells
were washed andmounted using n-propyl-gallate, and the cell staining
was detected using an Axiovert S-100 immunoﬂuorescencemicroscope
equipped with a CCD camera and the KS 300 image analyser pro-
gramme (Carl Zeiss Inc., Germany).
For the visualisation of the F-actin distribution, cell monolayers
were ﬁxed and permeabilised as described above and incubated in
500 ng/mL TRITC-phalloidin for 40 min at room temperature. After
washing, the stained monolayers were analysed using a Zeiss
LSM510 Meta laser scanning confocal microscope with a 543-nm ex-
citation laser. Individual images through the cell volume of similar
conﬂuent regions were collected, and optical sections near the apical,
medial (5 μm) and basal (9 μm) planes from monolayers (X–Y plane)
and their perpendicular planes (X–Z plane) were obtained. The images
shown are representative of at least three independent experiments.2.5. Cell extraction in Triton X-100 and western blotting
To evaluate the subcellular distribution of adherent junction pro-
teins, the samples were rinsed in PBS and incubated for 20 min at
4 °C in CSK extraction buffer (50 mM NaCl, 10 mM Pipes, pH 6.8,
3 mMMgCl2, 0.5% Triton X-100 (TX-100), 300 mM sucrose containing
1 mM orthovanadate, 20 mM NaF, and protease inhibitor cocktail
(1:100, Sigma). The cells were scratched from the plates, homogenised,
and centrifuged at 10,000 g for 10 min at 4 °C. The supernatant, corre-
sponding to the TX-100-soluble fraction (cytosolic proteins), was re-
moved and stored at −20 °C. The pellet was resuspended in SDS
buffer (20 mM Tris–HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA, and 1%
SDS) and boiled at 100 °C for 10 min. After centrifugation for 10 min
at 10,000 g, the supernatant, corresponding to the TX-100-insoluble
fraction (cytoskeleton-linked proteins), was removed and stored at−
20 °C for later analysis.
To obtain total cell lysates, the samples were rinsed and incubated
for 20 min at 4 °C in extraction buffer (150 mM NaCl, 10 mM Hepes,
pH 7.3, 0,2% sodium dodecyl sulphate, 1% TX-100, 0.5% deoxycholate,
and 2 mM EDTA) containing 2 mM orthovanadate, 20 mM NaF, and
protease inhibitor cocktail (1:100, Sigma). The cells were then
scratched from the plates, homogenised and centrifuged at 11,000 g
for 10 min at 4 °C. The supernatant was collected and stored at−20 °C.
Equal amounts of protein (30 μg/lane of cell fractions or 60 μg/lane
for phosphorylated forms analysis) were electrophoretically separat-
ed by SDS-PAGE on 7.5% or 10% gels and transferred to nitrocellulose
sheets. The membranes were blocked and incubated overnight in pri-
mary antibodies against E-cadherin (1:5000), β-catenin (1:4000),
p120-catenin (1:2000), phospho-Src tyrosine 416 (1:500), phospho-
FAK tyrosine 397 (1:1000) andα-tubulin (1:500). After washing, mem-
braneswere incubated for 1 h in peroxidase-conjugated goat anti-rabbit
or anti-mouse secondary antibodies. Proteins were visualised using an
enhanced chemiluminescence kit (GE Healthcare, Chalfont St. Giles,
UK). Bands were quantiﬁed according to their optical densities using
LabWorks 4.6 (Bio-Rad Laboratories, Hercules, CA).
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The activities of the Rho and Rac proteins were determined using
speciﬁc pull-down assays, following the manufacturer's instructions
(Pierce, Rockford, IL, USA). Brieﬂy, Rhotekin RBD and PAK-1 PBD
bound to glutathione-agarose beads were used to precipitate GTP-
bound Rho and Rac, respectively, from cell lysates. The active and
total Rho and Rac were separated by 12% SDS-PAGE and visualised
by western blotting using speciﬁc antibodies against Rho (1:500)
and Rac (1:1000).
2.7. Scratch-healing assay
Caco-2 monolayers were serum-starved for 24 h, pre-treated for
1 h with kinase and GTPase inhibitors and scratched using a sterile pi-
pette tip. For each dish, three wounds were manually made, and the
three regular wound sites were veriﬁed under a microscope, selected
and marked. After washing with PBS, fresh media containing the in-
hibitors and LPA was added to the cells, which were incubated at
37 °C. Untreated and treated cells were permitted to migrate into
the denuded area and were photographed immediately after wounding
(0 h), 6 h after wounding, and at the end of the experiment (24 h). The
distance between the two edges of the injury was quantiﬁed from three
independent experiments. The values are represented as percentages
and plotted on the graph.
2.8. Cell proliferation
The relative viable cell numbers were determined by the crystal
violet assay. Brieﬂy, the same cell density used in the cell migration
assay (1.5×104 cells) was seeded for 4 h in multi-well culture plates,
incubated with cell culture medium with or without FBS and treated
with LPA for 24 h. The cell culture mediumwas removed, and the sur-
viving cells were then ﬁxed with ethanol for 10 min and stained with
0.05% (w/v) crystal violet in 20% ethanol for 10 min at room temper-
ature. The plates were washed extensively, air-dried, and solubilised
with methanol, and the optical densities were measured at 595 nm
using an ELISA reader (Spectra Max 190, Molecular Devices, Sunny-
vale, CA, USA).
2.9. Statistical analysis
Statistical analyses were carried out using GraphPad Prism version
5.0 for Windows (GraphPad Software, San Diego, CA, USA). For each
experiment, the data from triplicate samples were calculated and
are expressed as the mean±S.D. The statistics were performed
using a two-tailed ANOVA with post hoc Dunnett tests. Differences
were considered to be signiﬁcant for P-valuesb0.05.
3. Results
3.1. LPA causes adherent junction protein redistribution
Initially, we used immunoﬂuorescence to analyse the subcellular
localisation of E-cadherin, β-catenin and p120-catenin after LPA
treatment. Fig. 1A shows that the adherent junction proteins were
preferentially localised at cell–cell contacts in untreated cells. After
LPA treatment for 15, 30 and 60 min, cells in the monolayers dissoci-
ated from each other and exhibited a discontinuous staining pattern
and internalisation of adherent junction proteins, but the attachment
to the substratumwas maintained. The same effect was observed at 6,
24 and 48 h of LPA treatment (Supplemental data, Fig. 1). Because
junctional proteins are functional when they are linked to the cytoskel-
eton, we evaluated the subcellular distribution of E-cadherin, β-catenin
and p120-catenin by performing western blotting on the TX-100-
soluble and -insoluble cell fractions after treatment with LPA.Densitometric analysis of these proteins revealed a signiﬁcant translo-
cation from the insoluble to the soluble fraction when cells were incu-
bated in LPA (Fig. 1B), but the expression of these proteins was not
altered after 24 h of treatment (Fig. 1C). Together, these results indi-
cate that LPA mediates adherent junction disassembly in Caco-2
cells.
3.2. LPA modulates perijunctional actin cytoskeleton organisation
concomitantly to stress ﬁbres and focal adhesion formation
Caco-2 monolayers were serum-starved for 24 h (control) or treated
with 10 μMLPA for 15, 30 and 60 min, and the actin cytoskeletal organi-
sation was analysed through the entire cell monolayer with time-frame
confocal microscopy. Fig. 2A shows that, in the control group, the cells
had punctate labelling in the apical region, reﬂecting the presence of
actin at the microvillus and in the cell–cell contacts. At the medial
level, actin was predominant at intercellular junctions, and few small
stress ﬁbres were observed on the basal side. LPA treatment altered
the cell morphology at the analysed times, increasing the cell size. Ap-
parently, LPA did not alter the actin distribution in the apical region,
but reduced the continuous linear staining pattern in themedial region,
indicating that LPA alters perijunctional actin, and as expected, induced
the formation of longer stress ﬁbres. Again, this effect was also observed
at 6, 24 and 48 h of LPA treatment (Supplemental data, Fig. 2).
Because our results showed that LPA increased stress ﬁbres forma-
tion, and since these structures is accompanied by the assembly of
focal adhesions (Ridley and Hall, 1992), we decided to investigate
the distribution of focal adhesion kinase (FAK), a focal adhesion pro-
tein, in response to LPA using cell monolayers and confocal microsco-
py analysis. Fig. 2B shows that FAK localises throughout cell
monolayers at focal complexes as punctate spots in control cells.
After 15 min of LPA treatment, aside from a drastic increase in actin
bundles, the extent of FAK staining increased and became elongated,
and FAK was localised to the termini of stress ﬁbres, indicating focal
adhesion formation. This effect was also observed at 30 min of LPA
treatment but was reduced after 1 h (data not shown).
It is widely accepted that FAK autophosphorylation on tyrosine
residue 397 recruits Src, which in turn phosphorylate other sites on
FAK that are needed for maximal FAK-associated activity (Schlaepfer
et al., 2004). This activated FAK–Src complex could promote multiple
intracellular signalling cascades involved in the disassembly of cell–
cell contacts and cell migration (Avizienyte et al., 2002; Jiang et al.,
2006). To conﬁrm that our immunoﬂuorescence data correlated
with the biochemical analysis of the FAK–Src complex, we examined
the phosphorylation levels of FAK and Src. We used an anti-phospho-
FAK antibody that detects phosphorylated Tyr 397 FAK and an anti-
phospho-Src antibody that detects phosphorylated Tyr 416 Src.
Fig. 2C shows that LPA stimulates the tyrosine phosphorylation of
both FAK and Src, predominantly at 15 and 30 min of treatment.
3.3. Src and Rho–Rock signalling mediate LPA-induced adherent junction
and actin cytoskeletal disassembly
Based on previous studies showing that LPA activates different sig-
nalling pathways (Noguchi et al., 2009), we decided to investigate
which one LPA mediates to induce adherent junction disassembly in
Caco-2 cells. Cell monolayers were preincubated for 1 h with different
inhibitors of cell signalling, including H89 (PKA inhibitor), LY294002
(PI3 kinase inhibitor), PD153035 (EGFR inhibitor), PP2 (Src inhibitor),
toxin A from Clostridium difﬁcile (Rho inhibitor), and Y27632 (Rock in-
hibitor). The cells were then treated for 1 hwith 10 μMLPA supplemen-
ted with the respective chemical inhibitors. Of the inhibitors, the Src
inhibitor PP2 prevented the redistribution of p120-catenin but did not
abrogate LPA-induced E-cadherin and β-catenin redistribution. More-
over, Rho and Rock inhibitors impaired LPA-induced adherent junction
disassembly, as evidenced by the localisation of E-cadherin, β-catenin
Fig. 1. LPA causes adherent junction protein redistribution in Caco-2 cells. (A) Cell monolayers were serum-starved overnight (control), incubated in medium containing 10 μM LPA
for 15, 30 and 60 min, ﬁxed and stained for E-cadherin, β-catenin and p120-catenin immunoﬂuorescence. LPA caused adherent junction protein redistribution, indicating cell–cell
contact disassembly (Arrowheads). Scale bar, 10 μm. (B) Representative western blotting and densitometric analyses for E-cadherin, β-catenin and p120-catenin in the Triton X-100
insoluble (Ins) and soluble (Sol) fractions of cells that were incubated with LPA at the indicated times. Note that LPA induced the redistribution of the proteins from the insoluble to
the soluble fractions. In each case, the score was calculated using the following equation: arbitrary score=(amount of the protein in the insoluble fraction)/(amount of the protein
in the soluble fraction). (C) Representative western blotting and densitometric analyses of cells treatedwith 10 μM LPA for 24 h. Cells were homogenised in lysis buffer, and E-cadherin,
β-catenin and p120-cateninwere analysed bywestern blotting. In each case, the score was calculated using the following equation: arbitrary score=(O.D. of the analysed protein)/(O.D.
ofα-tubulin). O.D., optical density; E-cad, E-cadherin; β-cat, β-catenin; p120, p120-catenin. The scores for the control groupwere normalised to 1 in each case. Average scores±S.E.M. for
three independent experiments are shown. Signiﬁcantly different: *, Pb0.05; **, Pb0.01.
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This data, togetherwith theﬁnding that Src is required for focal adhesion
formation, indicates that LPA-mediated Src activation modulates cell–
cell and cell–substrate adhesions.Because stress ﬁbre and focal adhesion formation are well-known
cellular responses to Rho activation in other cell models (Ridley and
Hall, 1992) and as our observations showed that Rho inhibition pre-
vented LPA-mediated adherent junction disassembly, we investigated
Fig. 2. LPA modulates actin cytoskeletal organisation and focal adhesion formation. A) Representative confocal images of serum-starved Caco-2 cells (control), incubated with
10 μM LPA for different times as indicated and probed with TRITC-conjugated phalloidin. Optical sections of the X–Y plane close to the apical, medial (5 μm), or basal (9 μm) cell
sides and an X–Z plane. Note that LPA induced reorganisation of medial region at all analysed times. Arrowheads, stress ﬁbres. Scale bar, 20 μm. B) Caco-2 cell monolayers were
serum-starved overnight (control) and incubated in LPA-containing medium for 15 min. Cells were ﬁxed, stained for F-actin and FAK, and analysed by confocal microscopy. LPA
treatment increased actin bundle formation, and FAK was elongated and localised at the termini of stress ﬁbres, indicating focal adhesion formation (Arrowheads). Insets on the
superior-right part of each panel in the merge images indicate a higher magniﬁcation of the area marked with asterisks. Scale bar, 20 μm. C) Phosphorylation analysis of Src and
FAK. Cell monolayers were treated with 10 μM LPA as indicated, and total lysates were obtained and prepared for western blotting using speciﬁc antibodies against the phosphorylated
forms of Src at tyrosine 416 (p-Src) and FAK at tyrosine 397 (p-FAK). Band imageswere quantiﬁed by optical density in three independent experiments. The scorewas calculated using the
ratio between the analysed protein and α-tubulin as protein loading control. The score for the control group was normalised as 1 in each case, and statistical analyses were carried out
using ANOVA with a post hoc Dunnett test. *, Pb0.05 and ***, Pb0.001. O.D., optical density.
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pull-down assay. Fig. 3B shows that conﬂuent monolayers of Caco-2
cells have a basal level of activated Rho in the control group, whichwas increased after 1 h of LPA treatment. However, LPA did not
alter the levels of activated Rac. We then used immunoﬂuorescence
to evaluate the cellular distribution of Rock II and IQGAP, effector
Fig. 3. Src and Rho–Rock signalling mediates LPA-induced adherent junction disassembly. A) Caco-2 cells were serum-depleted (control) and treated with LPA for 1 h or pretreated
for 1 h with the inhibitors as indicated before incubation with LPA. Cells were ﬁxed and stained for E-cadherin, β-catenin and p120-catenin. The Src inhibitor PP2 prevented LPA-
induced p120-catenin redistribution but did not alter E-cadherin or β-catenin localisation. Rho and Rock inhibitors impaired adherent junction protein redistribution. Arrowheads
indicate LPA-mediated protein redistribution. Scale bar, 10 μm. B) Rho and Rac activity using pull-down assays. Caco-2 cells were serum-starved (control) and treated with LPA as
indicated. Fresh lysates were used to detect the relative amounts of Rho-GTP and Rac-GTP, respectively. The total levels of Rho and Rac were detected by western blotting in cell
lysates and used as a protein loading control. C) Representative immunoﬂuorescence images of RhoA, Rock II, Rac1 and IQGAP in cells treated with LPA for 1 h. LPA treatment in-
creased RhoA and Rock II at cell–cell contacts but not Rac1 and IQGAP. Scale bar, 10 μm.
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increased RhoA and Rock II at cell–cell contacts, but neither Rac1 nor
IQGAP were redistributed (Fig. 3C). Because the predominant mem-
brane-linked Rho GTPases are active, the labelling of Rac1 at cell–cell
contacts visualised in the control group probably corresponds to the
basal activity observed in the pull-down assay. Overall, these data sug-
gest that LPA activates Rho–Rock, which in turn lead to cell–cell con-
tacts disruption.
Next, we examined the signalling pathways triggered by LPA that
are responsible for modulating the actin cytoskeletal redistribution
based on the F-actin staining visualised by confocal microscopy. Cell
monolayers were serum-starved for 24 h, pretreated with selective
inhibitors prior to LPA treatment, and images were obtained in the
apical, medial and basal regions and in the X–Z plane. As shown in
Fig. 4, the Src inhibitor PP2 and the Rho inhibitor toxin A clearly re-
stored the actin ﬁlament distribution in the medial and basal region.The Rock inhibitor Y27632 partially abrogated the effects in the medi-
al region and, as expected, abrogated LPA-induced stress ﬁbres
(Fig. 4A). The inhibitors of PKA, PI3 kinase, and EGFR did not prevent
the LPA effects throughout the cell volume (Supplemental data, Fig.
4). We also evaluated whether Src is required for LPA-mediated Rho
activation. Cell monolayers were serum-starved for 24 h, pretreated
with the Src inhibitor PP2 for 1 h, and then treated for 1 h with 10 μM
LPA supplemented with PP2, and the levels of activated RhoA were
measured using a pull-down assay. Fig. 4B shows that the Src inhibitor
partially prevented LPA-induced RhoA activation, suggesting that Src
acts upstream of Rho–Rock signalling.
3.4. LPA-induced cell migration depends on Src and Rho–Rock signalling
Previous studies have shown that LPA increases cellmigration in dif-
ferent cell types (Shida et al., 2008; Xu et al., 2007). Here using the
Fig. 4. Src and Rho–Rock signalling mediate LPA-induced actin cytoskeletal disruption. A) Caco-2 cell monolayers were serum-starved overnight (control), incubated with 10 μM
LPA for 1 h or pretreated for 1 h with the inhibitors before incubation with LPA as indicated. Cells were ﬁxed, probed with TRITC-conjugated phalloidin, and analysed by confocal
microscopy. Representative optical sections in the X–Y plane close to the apical, medial (5 μm), or basal (9 μm) cell sides and an X–Z plane are shown. Src and Rho inhibitors re-
stored the pattern of actin ﬁlament distribution in the medial region and the LPA-induced stress ﬁbre organisation, effects partially abrogated by the Rock inhibitor. Arrowheads
indicate longer stress ﬁbres. Scale bar, 20 μm. B) Pull-down assay to detect Rho activity. Caco-2 cells were treated with LPA for 1 h or pretreated for 1 h with the Src inhibitor
PP2. The Src inhibitor partially prevented LPA-induced RhoA activation.
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Caco-2 cells. In serum-starved control monolayers, the wounds
remained open at 6 h and just started to close after 24 h in culture. How-
ever, LPA-treated cells migrated faster than the control cells, initiated
healing at 6 h of treatment, and almost completely closed the wound
at 24 h (Fig. 5A–B). To further investigate the signalling pathways in-
volved in LPA-induced cellmigration, the cellswere pretreatedwith spe-
ciﬁc kinase inhibitors prior to the wound-healing assay. We observed
that PP2, toxin A and Y27632, which inhibit Src, Rho and Rock respec-
tively, prevented LPA-induced cell migration at 6 h of treatment. Inaddition, the Rock inhibitor completely abrogated LPA-induced wound
closure even after 24 h in culture. Other kinase inhibitors, such as H89
for PKA, LY294002 for PI3 kinase, and PD153035 for EGFR, did not pre-
vent the LPA-induced increases in cell migration (Supplemental data,
Fig. 5). The relative viable cell numbers were determined to verify that
cellswere indeedmigrating and not proliferating (Fig. 5C). This result in-
dicates that the same signalling pathway that modulates cell–cell disas-
sembly is also responsible for cell migration control.
We also investigated whether LPA-induced stress ﬁbres accompa-
nied focal adhesion formation at themigration front using subconﬂuent
Fig. 5. LPA-induced cell migration depends on Src and Rho–Rock signalling. A) Cell migration was evaluated using the wound healing technique. Caco-2 monolayers were serum-
starved (control), incubated with 10 μM LPA for 1 h or pre-treated for 1 h with the chemical inhibitors prior to LPA treatment. Cell migration was monitored at 6 and 24 h as in-
dicated in the Materials and methods. All of the inhibitors prevented LPA-induced cell migration at 6 h of treatment, and the Rock inhibitor (but neither Src nor Rho inhibitors)
completely abrogated the wound closure after 24 h of LPA treatment. Scale bar, 100 μm. B) The wound closures were measured and the migration rates were calculated as the dif-
ference between the two edges of the injury (Distance). The results are representative of three independent experiments. C) A proliferation assay was carried out after 48 h of treat-
ment in parallel with the cell motility assay. Statistical analyses were carried out using ANOVA with a post hoc Dunnett test. ***, Pb0.001 compared to the control group; ###,
Pb0.001 and ##, Pb0.01 compared to the LPA-treated cells.
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not project membrane protrusions, and FAK staining had a punctate la-
belling pattern throughout the cells. At 1 h of LPA treatment, it was pos-
sible to observe largemembrane protrusions, elongated focal adhesions,
and longer stress ﬁbres. At 15 and 30 min of LPA treatment, these struc-
tures were also observed (data not shown). Furthermore, Src and Rock
inhibition abrogated this LPA-induced migratory phenotype, corrobo-
rating our cell migration results.4. Discussion
The loss of cell–cell adhesion, actin cytoskeletal disorganisation,
and the acquisition of a migratory phenotype are initial steps of epi-
thelial cancer. However, there are few studies attempting to investi-
gate the role that LPA plays on these events, particularly during
colorectal cancer progression. Thus, the present study was designed
to explore the cell transduction mechanisms by which LPA could pro-
mote the loss of cell–cell adhesion, actin cytoskeletal disorganisation
conferring a migratory phenotype. Our results show for the ﬁrst time
that LPA can modulate both intercellular junctions and the actin cyto-
skeleton to induce a migratory phenotype in colon cancer cells. Fur-
thermore, we show that a regulatory cascade involving a crosstalkbetween Rho–Rock and Src–FAK may play an important role in the
regulation of these events.
We showed that LPA causes redistribution of the adherent junc-
tion proteins E-cadherin, β-catenin and p120-catenin in colon cancer
Caco-2 cells (Fig. 1A). LPA-induced intercellular junction dispersal
was also reported in ovarian cancer cells (Huang et al., 2008). Addi-
tionally, our results showing that LPA induces the disorganisation of
the perijunctional actin cytoskeleton (Fig. 2A) suggests that LPA-in-
duced adherent junction disassembly could be a consequence of
actin contraction. A previous study using HCT-116 colon cancer cells
analysed the long-term effects of LPA on junctional proteins and
showed that this biolipid causes aberrant nuclear accumulation of
β-catenin that promotes cell proliferation. We did not observe in-
creased cell proliferation (Fig. 5C), but these contradictory results
can be explained by the differences in the cell lines. Namely, Caco-2
cells are well differentiated, exhibit functional cell–cell contacts, and
are less invasive than HCT-116 cells (de Freitas Junior et al., 2011).
In most epithelial cancers, compromised E-cadherin function en-
hances the transition to metastasis (Carothers et al., 2006). Moreover,
E-cadherin is regulated by its cytoplasmic binding partners, catenins.
α- and β-catenins are associated with the actin cytoskeleton (Huang et
al., 2008; Leve et al., 2008), whereas p120-catenin modulates E-cadherin
stability at the cell surface (Davis et al., 2003). Thus, the fact that LPA
Fig. 6. Src and Rock control LPA-induced membrane protrusions in migrating cells. A) Subconﬂuent Caco-2 cell monolayers were serum-starved (control) and incubated in LPA for
1 h or pre-treated for 1 h with the chemical inhibitors of Src kinase (PP2) and Rock (Y27632) prior to LPA treatment. Cells were ﬁxed and stained for F-actin and FAK and analysed
using confocal microscopy. LPA treatment induced the formation of large membrane protrusions (Arrowheads) and elongated focal adhesion (Arrows), which were abrogated by Src
and Rock inhibitors. Insets on the superior right part of each panel in merge images indicate a higher magniﬁcation of the area marked with asterisks. Scale bar, 20 μm. B) A model
for the regulation of the LPA-induced migratory phenotype. (I) LPA, through its G protein-coupled receptors, induces adherent junction disassembly by a Src-dependent and/or
-independent mechanism. Thus, Src activation can induce the redistribution of p120-catenin and activate Rho–Rock. Alternatively, can also directly activate Rho/Rock and induce
adherent junction disruption. (II) LPA activates G protein-coupled receptors to trigger FAK/Src complex activation, which, in turn, recruits Rho/Rock to mediate focal adhesion (FA)
and stress ﬁbre formation. PP2: Src inhibitor; toxin A: Rho inhibitor; Y27632: Rock inhibitor. ECM, extracellular matrix; FAK, focal adhesion kinase.
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tions to the cytosol could explain the increased cell migration observed
here (Fig. 5).
A study showed that LPA increases the interaction between acti-
vated Src and p120-catenin, leading to decreasedα- and β-catenin in-
teraction in ovarian cancer cells (Huang et al., 2008). We found that
LPA-induced adherent junction and actin cytoskeletal disorganisation
in colon cancer cells are Src- and Rho–Rock-dependent (Figs. 3A and
4), and that Srcmainly participates in the redistribution of p120-catenin
(Fig. 3A). Additionally, it was shown that LPA enhances colon cancer cell
growth and apoptosis protection after 3 days of treatment, both in a
MAPK- and PI3K-dependent manner (Sun et al., 2009). Given that
EGFR, MAPK and PI3K did not reverse the effects of LPA in our study,
it is possible that their activations are important late events that
modulate cell growth, while Src activity is an initial cell signal that
is necessary to trigger adherent junction and actin cytoskeletal
disorganisation.
It is known that Rho GTPases modulate the function of adherent
junctions, and that G protein-coupled receptors, such as those for
LPA, act through a variety of α subunits to activate different signalling
pathways. In this context, Rho could be activated through the Gα12
and Gα13 family (Bian et al., 2006). Interestingly, it has been shown
in MDCK cells that Gα12 and Gα13 signalling disrupts adherent junc-
tions via Src and Rock, respectively (Donato et al., 2009; Meyer et al.,
2003). Therefore, our results suggest that LPA could activate RhoA–
Rock directly through its G protein-coupled receptors or via Src to
disrupt the adherent junctions. Also, we have previously shown that
a low-calcium medium disrupts adherent junctions and the actin cy-
toskeleton through Rho-Rock signalling in Caco-2 cells (Leve et al.,
2008). Here we showed that LPA activates RhoA (but not Rac1) and
recruits Rho and Rock II to cell–cell contacts (Fig. 3B–C). Thus, be-
cause Rho and Rock inhibitors abrogated LPA-induced adherent junc-
tion and actin cytoskeletal disassembly (Figs. 3A and 4, respectively),
and as nonmusclemyosin II inhibition impaired adherent junction
formation in colon cells (Ivanov et al., 2007), we suggest that adher-
ent junction disruption is mediated by actin–myosin contraction.
Coordinated remodelling of cell–cell and cell–substrate adhesions
with assembly and disassembly of focal adhesions are key steps in
cell migration. So, we investigated whether the same signalling path-
way that modulates the reorganisation of cell–cell contacts could also
modulate focal adhesions. It is known that Src localises to peripheral
cell-substrate adhesions, where it regulates the turnover of focal ad-
hesion through FAK phosphorylation (Lee et al., 2010; Webb et al.,
2004). Our results showing that Src participates in the LPA effects
on the p120-catenin redistribution, the longer stress ﬁbres and
focal adhesion formation, FAK activation, and cell migration suggests
that reciprocal regulation between the two types of adhesions can
occur during Src-mediated cell migration, as previously described
(Avizienyte et al., 2002) and points LPA as a stimulus for Src activa-
tion in colon cancer cells.
FAK is a non-receptor tyrosine kinase located at focal adhesions
and is crucial for cell movement. It is activated in response to G pro-
tein-coupled receptors, including those for LPA among others (Jiang
et al., 2006), and its phosphorylation leads to the recruitment and ac-
tivation of Src (Schlaepfer et al., 2004). Our results agree with previ-
ous studies showing that LPA induces FAK activation and cell
migration in other cell types (Bian et al., 2006; Jiang et al., 2006). It
has been suggested that FAK recruits proteins that contribute to the
dynamic remodelling of adhesions through a Src- and Rho-dependent
cascade (Webb et al., 2004). Our results showing that a) LPA activates
Rho in a Src-dependent manner (Fig. 4B), b) LPA induces FAK activa-
tion through the phosphorylation of the tyrosine residue speciﬁc for
Src (Fig. 2B–C), and c) Rho and Rock activities are required for the
LPA-induced migration (Fig. 5) all support this hypothesis. Moreover,
we showed that Src and Rock inhibitors in LPA-treated subconﬂuent
cells prevent the wide membrane protrusions that are crucial forcell migration. Interestingly, mature focal adhesions were abrogated
by Rock inhibition but not Src inhibition (Fig. 6A). This is consistent
with studies showing that cells lacking Src family members are still
able to assemble enlarged focal adhesions, but with a slower turnover
(Lee et al., 2010; Webb et al., 2004). Together, these data suggest that
Src and Rock inhibition prevent cell migration by impairing proper
focal adhesion dynamics.
It was shown that the activation of tyrosine kinases by G protein-
coupled receptors is required for the efﬁcient stimulation of Rho sig-
nalling (Sah et al., 2000). Indeed, many G protein-coupled receptors
are activators of FAK, which indicates a close link between FAK activa-
tion and Rho signalling (Bian et al., 2006) and suggests that LPA re-
ceptors could activate FAK. In agreement, we showed here that LPA
induces activation of FAK–Src complex in Caco-2 cell monolayers
(Fig. 2). Some studies suggested that Src is upstream of RhoA because
Src inhibits RhoA in a p190RhoGAP-dependent pathway (Haskell et
al., 2001). Also, Src phosphorylates RhoGDI, decreasing its ability to
bind and inhibits RhoA, Rac and Cdc42 (DerMardirossian et al., 2006).
Consistent with this latter possibility and with ﬁndings showing that
RhoA is active in the leading edge of migrating cells (Pertz et al.,
2006), our results indicate that active Src is upstreamof RhoA activation
(Fig. 4B) because Src inhibition decreased Rho activation, and because
LPA induced Src activation at 15 min of treatment while Rho was acti-
vated at 1 h. It is also possible that Src phosphorylates Rock directly to
reduce Rho–Rockmediated contraction force and control focal adhesion
turnover and directionalmigration, as shown recently (Lee et al., 2010).
However, whether Src activation occurs directly by any speciﬁc LPA re-
ceptor, by E-cadherin internalisation, or directly by FAK, remains to be
determined. Some studies have shown that LPA activates Rac and in-
duces lamellipodium formation (Jourquin et al., 2006), and that Src
phosphorylates Tiam, a guanine exchange factor that activates Rac,
leads to adherent junction disruption and cell migration (Woodcock
et al., 2009). We observed cell protrusions formation in subconﬂuent
Caco-2 cells (Fig. 6A), consistent with increased cell migration after
LPA treatment (Fig. 5), butwe did not detect active Rac (Fig. 3B). Consis-
tent with this result, it has already been shown that lamellipodium can
induce cell migration in a Rac-independent manner (Spaargaren and
Bos, 1999; Yip et al., 2007).
In summary, we have shown that LPA modulates cell–cell adhe-
sion disassembly, actin cytoskeletal remodelling, and focal adhesion
turnover, three events important to induce cell migration. We suggest
that LPA acts through a mechanism involving Src activation in the api-
cal cell compartment (where it causes p120-catenin internalisation
either directly or through Rho/Rock activation to modulate adherent
junction disassembly) and in the basal cell compartment (where Src
activity forms the Src–FAK complex to recruit Rho/Rock and induce
stress ﬁbre and focal adhesion formation) (Fig. 6B). We propose
that a similar molecular event may regulate the initial steps of colo-
rectal cancer progression.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ejphar.2011.09.006.
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